{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T01:46:21Z","timestamp":1776131181655,"version":"3.50.1"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100010586","name":"Haukeland\u00a0Universitetssjukehus","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010586","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005416","name":"Norges Forskningsr\u00e5d","doi-asserted-by":"publisher","award":["288164"],"award-info":[{"award-number":["288164"]}],"id":[{"id":"10.13039\/501100005416","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005036","name":"Universitetet i Bergen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005036","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.msard.2020.102691","type":"journal-article","created":{"date-parts":[[2020,12,21]],"date-time":"2020-12-21T16:38:40Z","timestamp":1608568720000},"page":"102691","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Comorbidity in multiple sclerosis patients from Nordland County, Norway \u2013 validated data from the Norwegian Patient Registry"],"prefix":"10.1016","volume":"48","author":[{"given":"Espen","family":"Benjaminsen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kjell-Morten","family":"Myhr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7654-5897","authenticated-orcid":false,"given":"Nina","family":"Grytten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0940-3581","authenticated-orcid":false,"given":"Karl Bj\u00f8rnar","family":"Alstadhaug","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2020.102691_bib0001","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/S0140-6736(18)30481-1","article-title":"Multiple sclerosis","volume":"391","author":"Thompson","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.msard.2020.102691_bib0002","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1136\/jnnp-2017-317509","article-title":"Time matters in multiple sclerosis: can early treatment and long-term follow-up ensure everyone benefits from the latest advances in multiple sclerosis?","volume":"89","author":"Cerqueira","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.msard.2020.102691_bib0003","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1212\/01.wnl.0000333252.78173.5f","article-title":"Comorbidity delays diagnosis and increases disability at diagnosis in MS","volume":"72","author":"Marrie","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2020.102691_bib0004","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1212\/WNL.0000000000002543","article-title":"Examining the effects of comorbidities on disease-modifying therapy use in multiple sclerosis","volume":"86","author":"Zhang","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2020.102691_bib0005","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/ene.12883","article-title":"Disease-modifying treatments for multiple sclerosis - a review of approved medications","volume":"23","author":"Torkildsen","year":"2016","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.msard.2020.102691_bib0006","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/ene.13819","article-title":"Multiple sclerosis - a review","volume":"26","author":"Dobson","year":"2019","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.msard.2020.102691_bib0007","unstructured":"Statistics Norway at https:\/\/www.ssb.no\/en\/statbank\/table\/07459\/."},{"key":"10.1016\/j.msard.2020.102691_bib0008","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/ana.410130302","article-title":"New diagnostic criteria for multiple sclerosis: guideline for research protocols","volume":"13","author":"Poser","year":"1983","journal-title":"Ann Neurol"},{"key":"10.1016\/j.msard.2020.102691_bib0009","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/ana.1032","article-title":"Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis","volume":"50","author":"McDonald","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1016\/j.msard.2020.102691_bib0010","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","article-title":"Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria","volume":"69","author":"Polman","year":"2011","journal-title":"Ann Neurol"},{"key":"10.1016\/j.msard.2020.102691_bib0011","doi-asserted-by":"crossref","first-page":"e01422","DOI":"10.1002\/brb3.1422","article-title":"Validation of the multiple sclerosis diagnosis in the Norwegian Patient Registry","volume":"9","author":"Benjaminsen","year":"2019","journal-title":"Brain Behav"},{"key":"10.1016\/j.msard.2020.102691_bib0012","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/0021-9681(70)90054-8","article-title":"The pre-therapeutic classification of co-morbidity in chronic disease","volume":"23","author":"Feinstein","year":"1970","journal-title":"J of chronic diseases"},{"key":"10.1016\/j.msard.2020.102691_bib0013","first-page":"453","article-title":"Cancer incidence in five continents","volume":"3","author":"Waterhouse","year":"1976","journal-title":"IARC Sci Pub"},{"key":"10.1016\/j.msard.2020.102691_bib0014","unstructured":"Cancer Registry of Norway at https:\/\/www.kreftregisteret.no\/globalassets\/cancer-in-norway\/2016\/cin-2106.pdf."},{"key":"10.1016\/j.msard.2020.102691_bib0015","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s00415-006-0395-5","article-title":"Outdoor activities and diet in childhood and adolescence relate to MS risk above the Arctic Circle","volume":"254","author":"Kampman","year":"2007","journal-title":"J Neurol"},{"key":"10.1016\/j.msard.2020.102691_bib0016","doi-asserted-by":"crossref","first-page":"3787","DOI":"10.3892\/ol.2017.5898","article-title":"Association between non-melanoma and melanoma skin cancer rates, vitamin D and latitude","volume":"13","author":"Rivas","year":"2017","journal-title":"Oncol Lett"},{"key":"10.1016\/j.msard.2020.102691_bib0017","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1136\/jech.58.2.142","article-title":"Skin cancer in people with multiple sclerosis: a record linkage study","volume":"58","author":"Goldacre","year":"2004","journal-title":"J Epidemiol Community Health"},{"key":"10.1016\/j.msard.2020.102691_bib0018","first-page":"973","article-title":"Cancer risk in multiple sclerosis: findings from British Columbia","volume":"135","author":"Kingwell","year":"2012","journal-title":"Canada. Brain"},{"key":"10.1016\/j.msard.2020.102691_bib0019","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.msard.2018.12.014","article-title":"Multiple sclerosis and cancer incidence: A Danish nationwide cohort study","volume":"28","author":"N\u00f8rgaard","year":"2019","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.msard.2020.102691_bib0020","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/ene.12267","article-title":"Increased breast cancer risk for patients with multiple sclerosis: a nationwide population-based cohort study","volume":"21","author":"Sun","year":"2014","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.msard.2020.102691_bib0021","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s10654-013-9853-4","article-title":"Smoking and multiple sclerosis susceptibility","volume":"28","author":"Hedstr\u00f6m","year":"2013","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.msard.2020.102691_bib0022","article-title":"Risk of cancer among multiple sclerosis patients, siblings, and population controls: A prospective cohort study","author":"Grytten","year":"2019","journal-title":"Mult Scler"},{"key":"10.1016\/j.msard.2020.102691_bib0023","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","article-title":"Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies","volume":"390","author":"Ng","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.msard.2020.102691_bib0024","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/s00415-016-8340-8","article-title":"Multiple sclerosis and inflammatory bowel diseases: a systematic review and meta-analysis","volume":"264","author":"Kosmidou","year":"2017","journal-title":"J Neurol"},{"key":"10.1016\/j.msard.2020.102691_bib0025","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1530\/EJE-13-0459","article-title":"Changes in the prevalence of hypothyroidism: the HUNT Study in Norway","volume":"169","author":"Asvold","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"9","key":"10.1016\/j.msard.2020.102691_bib0026","article-title":"Co-occurrence of autoimmune thyroid disease in a multiple sclerosis cohort","volume":"2","author":"Sloka","year":"2005","journal-title":"J Autoimmune Dis"},{"key":"10.1016\/j.msard.2020.102691_bib0027","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1159\/000339757","article-title":"The incidence and prevalence of thyroid disease do not differ in the multiple sclerosis and general populations: a validation study using administrative data","volume":"39","author":"Marrie","year":"2012","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.msard.2020.102691_bib0028","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1007\/s00125-018-4681-4","article-title":"Decreasing incidence of pharmacologically and non-pharmacologically treated type 2 diabetes in Norway: a nationwide study","volume":"61","author":"Ruiz","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/j.msard.2020.102691_bib0029","first-page":"1386","article-title":"Incidence and prevalence of rheumatoid arthritis in the county of Troms, northern Norway","volume":"27","author":"Riise","year":"2000","journal-title":"J Rheumatol"},{"key":"10.1016\/j.msard.2020.102691_bib0030","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/epi.12972","article-title":"Prevalence and etiology of epilepsy in a Norwegian county-A population based study","volume":"56","author":"Syvertsen","year":"2015","journal-title":"Epilepsia"},{"key":"10.1016\/j.msard.2020.102691_bib0031","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1177\/1352458514564486","article-title":"A systematic review of the incidence and prevalence of sleep disorders and seizure disorders in multiple sclerosis","volume":"21","author":"Marrie","year":"2015","journal-title":"Mult Scler"},{"key":"10.1016\/j.msard.2020.102691_bib0032","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1176\/appi.ajp.158.7.1091","article-title":"A Norwegian psychiatric epidemiological study","volume":"158","author":"Kringlen","year":"2001","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.msard.2020.102691_bib0033","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1212\/01.wnl.0000178998.95293.29","article-title":"Psychotic disorders in MS: population-based evidence of an association","volume":"65","author":"Patten","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2020.102691_bib0034","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000007251","article-title":"Traditional risk factors may not explain increased incidence of myocardial infarction in MS","volume":"92","author":"Marrie","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2020.102691_bib0035","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1161\/CIRCULATIONAHA.115.016960","article-title":"Trends in Modifiable Risk Factors Are Associated With Declining Incidence of Hospitalized and Nonhospitalized Acute Coronary Heart Disease in a Population","volume":"133","author":"Mannsverk","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.msard.2020.102691_bib0036","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.msard.2015.08.005","article-title":"Mortality and comorbidities in patients with multiple sclerosis compared with a population without multiple sclerosis: An observational study using the US Department of Defense administrative claims database","volume":"4","author":"Capkun","year":"2015","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.msard.2020.102691_bib0037","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1161\/STROKEAHA.114.008387","article-title":"Time trends in incidence and case fatality of ischemic stroke: the troms\u00f8 study 1977-2010","volume":"46","author":"Vangen-L\u00f8nne","year":"2015","journal-title":"Stroke"}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034820307653?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034820307653?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:50:29Z","timestamp":1761900629000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034820307653"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":37,"alternative-id":["S2211034820307653"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2020.102691","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comorbidity in multiple sclerosis patients from Nordland County, Norway \u2013 validated data from the Norwegian Patient Registry","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2020.102691","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102691"}}